Regulation of cancer cell migration and bone metastasis by RANKL.
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Bone metastases are a frequent complication of many cancers that result in severe disease burden and pain. Since the late nineteenth century, it has been thought that the microenvironment of the local host tissue actively participates in the propensity of certain cancers to metastasize to specific organs, and that bone provides an especially fertile 'soil'. In the case of breast cancers, the local chemokine milieu is now emerging as an explanation for why these tumours preferentially metastasize to certain organs. However, as the inhibition of chemokine receptors in vivo only partially blocks metastatic behaviour, other factors must exist that regulate the preferential metastasis of breast cancer cells. Here we show that the cytokine RANKL (receptor activator of NF-kappaB ligand) triggers migration of human epithelial cancer cells and melanoma cells that express the receptor RANK. RANK is expressed on cancer cell lines and breast cancer cells in patients. In a mouse model of melanoma metastasis, in vivo neutralization of RANKL by osteoprotegerin results in complete protection from paralysis and a marked reduction in tumour burden in bones but not in other organs. Our data show that local differentiation factors such as RANKL have an important role in cell migration and the tissue-specific metastatic behaviour of cancer cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MDA-231 cells and other human breast cancer cells have been shown to express RANK (101, 336)”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [336]
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Self-citationInvolvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Self-citationMetastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
The microenvironment of the tumour–host interface
Liotta, L. A., & Kohn, E. C. (2001) · Nature · doi:10.1038/35077241 · Cited by 2,310
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Fata, J. E., Kong, Y.-Y., Li, J., Sasaki, T., Irie-Sasaki, J., Moorehead, R. A., Elliott, R., Scully, S., Voura, E. B., Lacey, D. L., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00103-3 · Cited by 756
Self-citation
Cited by
Items 801–864 of 864
Papi, B. N. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2023.tde-22082023-154704
Rôle du récepteur RANK dans la régulation du métabolisme énergétique hépatique et adipocytaire
Phan, F. (2022) · theses.fr (ABES) · doi:10.70675/009ba81az6addz47b3z9e33zcc6ad1543dcb
Brouns, A. (2024) · Research Publications (Maastricht University) · doi:10.26481/dis.20240529ab
Rajković, S., & Sopta, J. P. (2024) · Medicinski podmladak · doi:10.5937/mp75-43870
Oral Cavity as a Remote Destination of Cancer Metastasis
Najary, S., Azangou‐Khyavy, M., Zarabadi, M. S., Farzanegan, P., Mokhlesi, A., Siahvoshi, S., & Soltani, N. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_382
Fukushima, N., Masuda, T., Furukawa, K., Tsuboi, K., Takahashi, K., Yuda, M., Tsunematsu, M., Ikegami, T., Yano, F., & Eto, K. (2025) · Oncology Letters · doi:10.3892/ol.2025.14925
Kostní markery u metastazujících tumorů a děje v zákulisí
Palička, V. (2008) · Klinická biochemie a metabolismus · doi:10.61568/kbm.2008.027
Elsamany, S. A., Elemam, O., Hassanin, F., Algahami, A., Alghanmi, H., & Elnaghi, K. (2025) · World Journal of Oncology · doi:10.14740/wjon2546
“Noteworthy, RANK was found to be expressed in primary breast cancer cells as well [7].”
Immune Compartments and Extracellular Matrix Crosstalk Involved in Tumor Dissemination
Malvincini, M., & Alaniz, L. D. (2025) · Springer eBooks · doi:10.1007/978-3-032-00759-9_62
IMBALANCE BETWEEN NEUTROPHIL ELASTASE AND ELAFIN PROMOTES BREAST CANCER GROWTH AND PROGRESSION
Caruso, J. A. (2014) · Digital Commons-TMC (Texas Medical Center)
Majima, S., Wada, T., & Ikeda, M. (2012) · Folia Pharmacologica Japonica · doi:10.1254/fpj.140.295
Self-citationMei, S., Alchahin, A. M., Τσέα, Ι., Kfoury, Y. S., Hirz, T., Jeffries, N. E., Zhao, T., Xu, Y., Zhang, H., Sarkar, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25101129
Κοντοτάσιου, Ι. Χ. (2023) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.38396
Steiner, L. (2015) · reposiTUm (TU Wien) · doi:10.34726/hss.2015.25470
Wimberger, P., Blohmer, J.-U., Krabisch, P., Link, T., Just, M., Sinn, B. V., Simon, E., Solbach, C., Fehm, T., Denkert, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619398
Mei, S., Alchahin, A. M., Τσέα, Ι., Kfoury, Y. S., Hirz, T., Jeffries, N. E., Zhao, T., Xu, Y., Zhang, H., Sarkar, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25101139
Wimberger, P., Blohmer, J.-U., Krabisch, P., Link, T., Just, M., Sinn, B. V., Simon, E., Solbach, C., Fehm, T., Denkert, C., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22619401
Miranda, J. A. I. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.5281/zenodo.8386358
Rajković, S. (2023) · National Repository of Dissertations in Serbia
Unraveling luminal breast cancer heterogeneity
Figueras-Puig, C. (2022) · Repositori digital de la UPF (Universitat Pompeu Fabra)
Breast cancer cells affect bone cell differentiation and the bone microenvironment
Fong, J. E. (2011) · eScholarship@McGill (McGill) · doi:10.82308/9420
Schwenk, R. (2018) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt)
Radiation treatment following stabilization of bone destructed by malignant disease
Wolanczyk, M. (2013) · University Library BOCHUM (Ruhr University Bochum)
Lucas, S. (2021) · OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg)
Characterization of pain associated with skeletal diseases
Abdelaziz, D. M. (2015) · doi:10.82308/2488
Interaction of breast cancer cells with osteoclasts
Hussein, O. (2011) · doi:10.82308/28992
Bewirkt das Bisphosphonat Zoledronsäure eine Redifferenzierung von Mammakarzinomzellen in vitro?
Hoberg, C. (2014) · Dokumentenrepositorium der RUB (Ruhr University Bochum)
Innovative methods to study the regulation of osteoclastic resorption and migration
Maria, S. M. (2014) · eScholarship@McGill (McGill) · doi:10.82308/2044
Ryser, M. (2012) · eScholarship@McGill (McGill)
Μελέτη του παθογενετικού ρόλου της κυτταροκίνης rankl σε διαγονιδιακά ζωικά πρότυπα
Niti, A. (2015) · EduLLL - Greek Educational Content Repository (EKT)
Protein-protein interaction prediction using local threading
Pulim, V. (2008) · DSpace@MIT (Massachusetts Institute of Technology)
Crosstalk Between Metastatic Cancer Cells and the Bone Microenvironment
Zhou, K., Zhang, H., & Yu, Y. (2025) · Cancer Nexus · doi:10.1002/cnx2.70014
Zhou, F., Li, P., Zou, J. P., Lei, W., Han, W., Gu, Y., Hu, Y. L., Zeng, C., Li, J., Cao, J., et al. (2026) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-04186-2
“…protein can enhance the expression of receptor activator of nuclear factor kappa-B ligand, activating osteoclasts and inducing the receptor activator of nuclear factor kappa-B ligand/receptor activator of nuclear factor kappa-B pathway, thereby promoting tumor stemness and metastasis [39].”
Giorello, M. B., Borzone, F. R., Sanmartin, M. C., Martinez, L. M., Sarkar, M., Sarkar, T. R., Labovsky, V., Wernicke, A., & Chasseing, N. A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1766643
Okamoto, K., & Takayanagi, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00001-3
乳癌におけるCYLDの臨床的重要性、新たな抗NF-κB関連治療戦略の構築へ向けて
Hayashi, M. (2014) · Institutional Repositories DataBase (IRDB)
Importance of CD105(+)/CD34(-) stromal mesenchymal cells in breast cancer progression
Giorello, M. B. (2024) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Pivotal roles of aminolevulinic acid (ALA) uptake transporters in ALA-photodynamic therapy
Lai, H. W. (2021) · Institutional Repositories DataBase (IRDB)
BMPシグナルは大腸癌において予後マーカーとなり、フレイルと関連している
Sawata, S. (2025) · Institutional Repositories DataBase (IRDB)
Homéogènes Dlx, signalisation RANK/RANKL et ostéosarcomes
Navet, B. (2016) · theses.fr (ABES) · doi:10.70675/9f9d3d45zb9e6z496dz8aa6z8b9e2722f757
Hypoxia signaling in osteoblast lineage cells promotes Systemic breast cancer growth and metastasis
Devignes, C.-S. (2017) · theses.fr (ABES) · doi:10.70675/b1e1422cza48ez40ccza335z2c9347b585b2
Delliaux, C. (2017) · theses.fr (ABES) · doi:10.70675/ee5c5a3ez961dz416dz8018z51380eef6213
Implication de la Connexine 43 dans le développement de métastases osseuses d'origine prostatique
Boucher, J. (2018) · theses.fr (ABES) · doi:10.70675/61c5e7e2z5b24z4067z9a9az19eb1b310497
Role of the bone microenvironment in systemic breast cancer growth and metastasis
Aslan, Y. (2020) · theses.fr (ABES) · doi:10.70675/a6793073zd42dz4dacz843azd9606734d152
Role of osteoblast-lineage cells in the systemic control of breast cancer growth and metastasis
Sakr, L. H. D. (2023) · theses.fr (ABES) · doi:10.70675/179977d9z1e5dz4366z9f34z1c637ab6d71c
Oka, S., Kameda, T., Torii, D., Tsutsui, T. W., Tsubura, S., & Imai, A. (2026) · Dental Materials Journal · doi:10.4012/dmj.2025-314
Yuan, Z., Zhang, H., Xing, J., Cao, X., Liu, G., Tan, T., Zhao, C., & Yang, C. (2026) · Journal of bone oncology · doi:10.1016/j.jbo.2026.100793
“Tumor-derived factors stimulate osteoclast differentiation and bone resorption through pathways such as RANKL/RANK, IL-6, IL-11, PTHrP, and TGF-β -related signaling [37,63,64].”
Ma, C., Ma, C., Xing, X., Sun, C., Guan, L., Schiöth, H. B., & Liu, W. (2026) · 癌症:英文版 · doi:10.34133/cancomm.0053
“RANKL further enhances the migration of melanoma, breast, prostate, and lung cancer cells and promotes skeletal metastasis in experimental systems [ 282 – 284 ].”
Asano, T. (2019) · Institutional Repositories DataBase (IRDB) · doi:10.15083/0002002329
Advances in the role of astrocytes in glioma progression and therapy
Xu, X.-H., Wu, R., Fan, J., & Chen, X. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01934-2
Jiang, S., Ren, Y., Wang, Y., Li, Y., Miao, L., Liu, W., & Zhou, G. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1971063
“Critically, this cascade fosters an immunosuppressive tumor microenvironment (TME), a mechanism implicated in therapy resistance and adverse oncologic outcomes (38, 39).”
Lou, J., Gong, B., Li, Y., Guo, Y., Li, L., Wang, J., Liu, W., You, Z., Zhang, H., Pan, F., et al. (2024) · doi:10.3389/fimmu.2024.1332303.s001
Bouzid, A., Chelly, A., Tekari, A., Singh, N., Hansdah, K., Achour, I., Ayed, I. B., Jbeli, F., Charfeddine, I., Ramchander, P. V., et al. (2022) · doi:10.3389/fmed.2022.870244.s004
Brouns, A. J. W. M., Hendriks, L. E. L., den Berge, I. J. R.-V., Driessen, A. J. H. M., Roemen, G. M. J. M., van Herpen, B. L. J., Dekkers, Z., Heitzer, B., Leunissen, D. J. G., Moonen, L., et al. (2023) · doi:10.3389/fonc.2023.1145001.s001
David, M. (2010) · theses.fr (ABES) · doi:10.70675/ac5b78e8z9194z4a0cza6f5z1c8ec00cbbf7
“L’OPG, en bloquant RANK-L, inhibe in vitro la migration des cellules de carcinome prostatique DU-145 et PC-3 et, in vivo, la colonisation de la moelle osseuse par les cellules de mélanome B16F10 [47].”
Background
Metadata
- Authors
- Jones, D. H., Nakashima, T., Sanchez, O. H., Kozieradzki, I., Komarova, S. V., Sarosi, I., Morony, S., Rubin, E., Sarao, R., Hojilla, C. V., Komnenovic, V., Kong, Y.-Y., Schreiber, M., Dixon, S. J., Sims, S. M., Khokha, R., Wada, T., & Penninger, J. M.
- Affiliations
- Institute of Molecular Biotechnology (AT)
- University Health Network (CA)
- McGill University (CA)
- Amgen (United States) (US)
- University of Toronto (CA)
- Pohang University of Science and Technology (KR)
- Medical University of Vienna (AT)
- Western University (CA)
- Corresponding author
- Penninger, Josef M.
- ORCID
- Venue
- Nature
- Published
- 2006-03
- Volume
- 440
- Issue
- 7084
- Pages
- 692-696
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2051255001
- Cited by
- 796
- References
- 22
- Citations by year
- 2026: 10 · 2025: 21 · 2024: 24 · 2023: 32 · 2022: 33 · 2021: 43 · 2020: 43 · 2019: 39 · 2018: 28 · 2017: 43 · 2016: 36 · 2015: 42 · 2014: 45 · 2013: 47 · 2012: 68
- FWCI
- 18.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Open Access System for Information Sharing (Pohang University of Science and Technology) (submittedVersion)
- Funders
- European Commission
- Oesterreichische Nationalbank
- Canadian Institutes of Health Research
- National Cancer Institute
- Institute of Musculoskeletal Health and Arthritis
- Canadian Arthritis Network
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- RANKL, RANK, bone metastasis, tumor cell migration, osteoprotegerin, melanoma, breast cancer, tumor microenvironment, NF-κB signaling
- MeSH terms
- Animals, Bone Neoplasms, Breast Neoplasms, Carrier Proteins, Cell Differentiation, Cell Movement, Epithelial Cells, Female, Humans, Melanoma, Membrane Glycoproteins, Neoplasm Metastasis, Organ Specificity, Paralysis, Signal Transduction, Cell Death, Cell Line, Tumor, Cell Proliferation, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.